DNA METHYLATION-VALIDATED SMOKING STATUS IS NOT ASSOCIATED WITH RESPONSE TO BIOLOGIC THERAPY IN CROHN'S DISEASE (UEGW 2026) - Sep 28, 2026 - Abstract #LBP25; Pres time: Oct 18, 2026; 09:00 AM - 06:00 PM; Location: Hall 7 Poster Area; "We demonstrate that while self-reported smoking behavior is associated with cg05575921, neither are associated with response to anti-TNF, ustekinumab, or vedolizumab therapy in CD suggesting no evident association between smoking behavior and response to therapeutics."
Epigenetic controller • Late-breaking abstract • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease
|
|
K. Overberg 1; F. Mol 1; M. Ghiboub 2,1,3; S. van Zon 3; J. Satsangi 4; A.Y. Li Yim 1,5; G.R. D'Haens 3; W.J. de Jonge 1,3,6
|